The Board has remanded the Veteran's claims for neoplasm of the kidney and diabetic nephropathy and renal dysfunction due to service in Southwest Asia, as well as their secondary relationship to fibromyalgia. The VA examinations were inadequate and a new opinion is needed.
The deciding factor: The previous VA opinions did not adequately address the Veteran’s exposure claims or reconcile conflicting opinions.
- Claimed conditions
- neoplasm of the kidney, diabetic nephropathy and renal dysfunction
- How they argued it
- Secondary to another service-connected condition
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- February 22, 2021
- Citation
- 21009516
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 21009516.
What this means for you
A remand sends an issue back for more development, often a new examination or missing records. It does not award the benefit or decide the final outcome. The original decision explains the additional work ordered.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Dismissed
The Veteran's appeals for service connection and ratings were dismissed. The appeal for bilateral recurrent ear wax impaction was dismissed, as the Veteran withdrew his claim. Appeals for a compensable rating for pseudofolliculitis barbae (PFB), erectile dysfunction, residuals from neoplasm of the kidney, and hypertension were also dismissed.
- Granted
The Board granted an effective date of April 26, 2011 for the award of service connection for neoplasm of the kidney, nephrectomy associated with neoplasm of the kidney, and scarring associated with nephrectomy.
- Granted
The Board granted service connection for various conditions, including neoplasm of the kidney and lung cancer, effective October 2, 2020, based on herbicide exposure during service in Thailand.
- Remanded (sent back)
The Board remands the claim for a compensable rating for neoplasm of the kidney to obtain any outstanding VA treatment records from May 2023 onwards, as there is evidence suggesting possible recurrence of kidney cancer.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.